Ulla Wilking

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: CANCER MEDICINE. 2023;12(9):10840-10850
Planning for return to work during the first year after breast cancer metastasis: A Swedish cohort study
Johnsson A; Kiani NA; Gernaat SAM; Wilking U; Shabo I; Hedayati E
Article: EUROPEAN JOURNAL OF CANCER CARE. 2022;31(5):e13626
Use of sickness benefits by patients with metastatic breast cancer-A Swedish cohort study
Altena R; Gernaat SAM; Wilking U; Kiani NA; Johnsson A; Hedayati E
Article: NATURE REVIEWS CLINICAL ONCOLOGY. 2022;19(3):207-215
The value of anticancer drugs - a regulatory view
Pignatti F; Wilking U; Postmus D; Wilking N; Delgado J; Bergh J
Article: EUROPEAN JOURNAL OF CANCER CARE. 2021;30(1):e13353
Sickness absence and disability pension among swedish women prior to breast cancer relapse with a special focus on the roles of treatment and comorbidity
Gernaat SAM; Johnsson A; Altena R; Wilking U; Hedayati E
Article: BREAST. 2016;29:140-146
Societal cost of subcutaneous and intravenous trastuzumab for HER2-positive breast cancer - An observational study prospectively recording resource utilization in a Swedish healthcare setting
Olofsson S; Norrlid H; Karlsson E; Wilking U; Tennvall GR
Article: CHINESE CLINICAL ONCOLOGY. 2014;3(2):23
The positioning of economic principles under the changing conditions of the novel drug developmental process in cancer
Wilking N; Wilking U; Jonsson B
Article: BREAST CANCER RESEARCH AND TREATMENT. 2011;125(2):553-561
HER2 status in a population-derived breast cancer cohort: discordances during tumor progression
Wilking U; Karlsson E; Skoog L; Hatschek T; Lidbrink E; Elmberger G; Johansson H; Lindstrom L; Bergh J
Article: ACTA ONCOLOGICA. 2010;49(6):844-850
Trastuzumab use in breast cancer patients in the six Health Care Regions in Sweden
Wilking U; Jonsson B; Wilking N; Bergh J

Alla övriga publikationer

Meeting abstract: CANCER RESEARCH. 2020;80(4):p5-02-07-p5-02-07
Distribution of biomarker evaluation scores among the pathology departments of Sweden: Comparison study of 35,066 breast cancer cases
Acs B; Fredriksson I; Wilking U; Robertson S; Hartman J
Doctoral thesis: 2011
Studies of targeted therapy in breast cancer using trastuzumab : HER2 testing and trastuzumab treatment, clinical and economic evaluation
Wilking U
Meeting abstract: EUROPEAN JOURNAL OF CANCER. 2011;47:S337-S338
Clinically Used Breast Cancer Markers are Heterogeneous Throughout Tumour Progression
Lindstrom LS; Karlsso E; Wilking U; Bergh J
Meeting abstract: EUROPEAN JOURNAL OF CANCER, SUPPLEMENT. 2010;8(3):217
Uptake of trastuzumab (T) in selected European countries during the first 9 years after market introduction
Wilking U; Bergh J; Jonsson B; Kasteng F; Wilking N

Examina och utbildning

Medicine Doktorsexamen, Institutionen för onkologi-patologi, Karolinska Institutet, 2011

Artiklar

Alla övriga publikationer

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI